Table 1. Clinicopathological features of the overall series.
| Characteristics | LGSOC No. of patients (%) |
HGSOC No. of patients (%) |
p values |
|---|---|---|---|
| All cases | 25 | 55 | |
| Mean Age, years (± SEM) | 49.8 ± 3.0 | 56.8 ± 1.5 | 0.03 |
| Type of primary surgery | |||
| Cytoreduction | 25 | 55 | – |
| Residual tumor after primary surgery (cm) | |||
| 0 | 22 | 36 | 0.06# |
| < 1 | 3 | 14 | |
| > 1 | 0 | 5 | |
| FIGO Stage | |||
| I/II | 10 (40) | 8 (15) | 0.01 |
| III/IV | 15 (60) | 47 (85) | |
| Primary chemotherapy | |||
| None | 3 (12) | 1 (1.8) | 0.08§ |
| Platinum/paclitaxel | 17 (68.0) | 48 (87.3) | |
| Platinum-based | 4 (16.0) | 5 (9.1) | |
| Other | 1 (4) | 1 (1.8) |
P values were calculated using the Fisher's exact test;
#
No residual tumor versus any extent of residual disease;
§
No chemotherapy versus any type of chemotherapy.